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Abstract The dual function of the regulatory P-subunit of pro- 
tein kinase CK2 is highlighted by its ability to abolish calmodulin 
phosphorylation in contrast to its stimulatory effect on the phos- 
phorylation of peptide substrates. Here we show that a synthetic 
peptide reproducing the C-terminal region of the P-subunit 
(/3[17&215]) stimulates to a similar extent the phosphorylation 
of either the peptide substrate or calmodulin and also protects the 
catalytic a-subunit against thermal inactivation as efficiently as 
full-length P-subunit. These data show that the positive and neg- 
ative functions of the P-subunit reside in physically separated 
domains and that the elements responsible for positive regulation 
are located in the C-terminal region. 
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1. Introduction 
Protein kinase CK2 (formerly termed casein kinase-2 [l]) is 
a ubiquitous and pleiotropic SerlThr protein kinase whose im- 
plication in a variety of cellular functions is supported by a 
number of observations [24]. CK2 phosphorylates a wide spec- 
trum of target proteins, several of which are involved in gene 
expression and signal transduction, and its activity is invariably 
increased in transformed and proliferating cells. These observa- 
tions would imply some kind of cellular control, which, how- 
ever, is not evident in vitro, where CK2 is constitutively active 
toward most of its substrates. In searching for mechanism(s) 
capable of modulating CK2 activity, special attention has been 
devoted to its quaternary structure, composed of two catalytic 
(a and/or a’) and two non-catalytic @) subunits. The resulting 
holoenzyme is very stable and it does not dissociate except 
under denaturing conditions. Reconstitution experiments with 
recombinant subunits in conjunction with the use of the atypi- 
cal substrate calmodulin, whose phosphorylation is prevented 
instead of being increased by the/%subunit [5], disclosed a dual 
function: on the one hand the B-subunit increases the stability 
and the overall catalytic activity toward canonical substrates, 
while on the other hand it imposes an intrinsic down-regula- 
tion. This latter is evident with calmodulin, while being masked 
by the positive effect with canonical substrates [6,7]. Mutagene- 
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sis experiments suggested that while the negative regulation and 
its consequent relief by polybasic effecters are mediated by 
acidic residues in the N-terminal moiety of the B-subunit, pos- 
itive regulation is mainly exerted by the carboxyl-terminal do- 
main [6]. In order to check the validity of this hypothesis and 
to dissect the positive and negative roles of the P-subunit we 
have started a project aimed at the chemical synthesis of large 
fragments of the p-subunit to test their ability to mimick the 
diverse functions of the whole protein. Here, we show that a 
synthetic peptide reproducing about one-fifth of the whole se- 
quence, from residue 170 to the C-terminus, is able to protect 
against thermal inactivation and to stimulate up to 3-fold the 
basal activity of the catalytic subunit. However, it fails to sup- 
press the phosphorylation of calmodulin; on the contrary calm- 
odulin phosphorylation is stimulated in a mnaaer similar to that 
of canonical substrates. 
2. Materials and methods 
Synthetic peptides MSSSEEVSW, DLEPDEELEDNPNQSDL and 
NFKSPVKTIR, corresponding to the segments 1-9, 55-71 and 206- 
215 of the CK2 /?-subunit, respectively, were prepared as previously 
described [8,9]. The peptide VHPEYRPKRPANQFVPRLYGFKIH- 
PMAYQLQLQAASNFKSPVKTIR, reproducing the 17%215 seg- 
ment of the CK2 P-subunit, and its shorter fragment 170-192, have 
been prepared using Fmoc chemistry on an automatic synthesizer 
(Model 431-A, Applied Biosystems) equipped with a UV-detector (ABI 
Model 759 A) for the monitoring of the Fmoc deprotection. The C- 
terminal amino acid was linked to a hydroxy-methylphenoxymethyl 
resin (Wang resin) (0.05 mmol of 0.96 mmol,g/resin). The following 
acylation step was carried out by Fmoc amino acids (IO-fold excess) 
with appropriate side chain protecting groups, activated with N,N- 
dicycloexylcarbodiimide/l-hydroxybenzotriazole chemistry. After 
every coupling step the peptidyl resin was capped with acetic anhydride. 
Side chain protection was as follows: 2,2,5,7,8-pentamethylchroman- 
sulfonyl for arginine; trityl for asparagine, glutamine and histidine; 
tert-butyl for glutamic acid, serine, threonine and tyrosine; tert-buty- 
loxycarbonyl for lysine. After the final N-terminal deprotection the 
peptide was cleaved from the resin with trifluoroacetic acid/anisole/ 
ethanedithiol/ethyl methyl sulfide (95: 3 : 1 : 1) and purified by weak 
cation-exchange chromatography. The purity (> 95%) was evaluated by 
amino acid analysis and analytical high-pressure liquid chromatogra- 
phy. The synthesis of the peptide substrate RRRAADSDDDDD used 
in the present study was accomplished as previously described [IO]. 
Rat liver CK2 was prepared essentially as previously described [l l] 
with a further FPLC MonoQ chromatographic step. Its specific activity 
was 236 Ulmg, 1 U being defined as the catalytic activity transferring 
1 nmol of P per min into casein (80 PM) under standard conditions. 
Recombinant CK2a and -B subunits were prepared as previously de- 
scribed [12]. The specific activity ofCK2a preparation used in this study 
was 52 U/mg. 
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Phosphorylation conditions with either the synthetic peptide RRR- 
AADSDDDDD (100pM) or calmodulin (2.6pM) as phosphorylatable 
substrate (final volume 50 ~1) and evaluation of the phosphate incorpo- 
rated were as previously described [7]. Whenever the activity of the 
reconstituted holoenzyme (a plus B subunits) was assayed in the pres- 
ence ofp-derived peptides, these were mixed together with the/?-subunit 
prior to their addition to the a-subunit. Thermal stability was deter- 
mined from the residual catalytic activity after preincubation of the 
samples at 45°C [6]. Sucrose gradient ultracentrifugation was per- 
formed as previously described [6]. 
3. Results 
A schematic representation of the CK2 /l-subunit with its 
putative functional domains and the corresponding synthetic 
peptides employed in this study are illustrated in Fig. 1A. The 
effect of these peptides on the activity of the a-subunit (tested 
on the peptide substrate RRRAADSDDDDD) is shown in Fig. 
lB. While the peptide /3[55-711 leads to a slight decrease in 
activity, the peptides p[170-2151 and p[170-1921 stimulate the 
kinase activity up to 2-fold, thus behaving like the intact /?- 
subunit, though much less efficiently since stimulation by the 
whole P-subunit is several fold more pronounced (see below). 
In contrast shorter peptides reproducing the amino- and the 
carboxyl-terminal ends, ,4 l-91 and p[209-2 151, respectively, are 
ineffective up to 100 ,LLM concentration. 
The effect of peptidesp[5557 11, p[ 170-2 151 and/?[ 170-1921 on 
the catalytic activity of the a-subunit (see Fig. 1B) is not detect- 
able if they are added to the reconstituted holoenzyme (not 
shown). This finding is consistent with the concept that the 
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Fig. 1, Schematic representation of the P-subunit (A) and influence of 
p-subunit derived peptides on the catalytic activity of the a-subunit (B). 
The sequence of the P-subunit with its putative functional domains is 
schematically shown in A. Ser-209 represents the cdc2 kinase phospho- 
rylation site. The activity of the a-subunit (0.05 pg) either alone or in 
the presence of increasing concentrations of p-derived peptides (as 
indicated) was evaluated using the peptide substrate RRRAADSDD- 
DDD as previously described [7]. 
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Fig. 2. Peptidep[170-2151 counteracts the stimulation of CK2a activity 
by the B-subunit by preventing holoenzyme reconstitution. The a-sub- 
unit (0.13 ,uM) was incubated as in Fig. 1 B in the presence and absence 
of equimolar amounts of the P-subunit and /?[ 17&2 151 peptide as indi- 
cated. Aliquots of all the samples were assayed for catalytic activity 
using the peptide substrate RRRAADSDDDDD. Aliquots of the sam- 
ples denoted by an asterisk were also analyzed for the presence of free 
a-subunit and reconstituted ~5~ holoenzyme by sucrose density gradi- 
ent ultracentrifugation (inset). 
peptides influence CK2 activity by mimicking the effects of the 
corresponding regions of the p-subunit. Such a point of view 
is corroborated by the finding that the C-terminal peptide 
/3[ 170&215] counteracts in a dose dependent manner the effec- 
tive association of B- and a-subunits, as judged by activation 
experiments (Fig. 2). The ability of /?[ 170-2151 to compete out 
the P-subunit was also highlighted by parallel ultracentrifuga- 
tion experiments, showing that the C-terminal peptide also pre- 
vents the reconstitution of normal CL& heterotetramers (Fig. 
2, inset). 
A third line of evidence that the C-terminal peptide /?[170- 
2 151 possesses the elements responsible for positive interactions 
with the d-subunit is provided by the heat denaturation exper- 
iments of Fig. 3. Protection against thermal inactivation is one 
of the criteria for evaluating the effective binding of the /3- 
subunit to the d-subunit, the latter alone being intrinsically very 
heat labile [9]. As shown in Fig. 3, a similar protection is pro- 
vided by the /?[170-2151 peptide. Interestingly no significant 
protection could be observed with the truncated peptide /?[ 170- 
1921, despite its ability to stimulate CK2 activity almost as 
effectively as /3[ 170-2 151 (see Fig. 1 B). 
In order to further strengthen the conclusion that the positive 
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Fig. 3. Protection of a-subunit against thermal inactivation by the 
P-subunit and by the peptide /3[170-2151. The catalytic activity of the 
a-subunit (0.05 pug), either alone or in the presence of equimolar 
amounts of/?-subunit or 18 ,uM/?-derived peptides, was evaluated after 
preincubation at 45°C for the time indicated. 
effects of /?[170-2151 on both CK2 activity and stability are 
specifically due to its ability to mimick the properties of the 
C-terminal domain of the P-subunit, advantage has been taken 
of calmodulin, a CK2 substrate whose phosphorylation is pre- 
vented, rather than stimulated, by the P-subunit [5]. The acidic 
residues responsible for down-regulation of calmodulin phos- 
phorylation are located in the N-terminal moiety of the /I- 
subunit [7] and therefore are not included in the /3[170-2151 
peptide. It was therefore expected that, unlike the B-subunit, 
this peptide would prove incapable of preventing calmodulin 
phosphorylation. Actually, as shown in Fig. 4 the peptide 
/I[ 170-2151 not only fails to suppress calmodulin phosphoryla- 
tion but even stimulates it to the same extent observed with 
canonical peptide substrates. This provides clear-cut evidence 
that the positive and negative regulatory effects of theg-subunit 
can be physically dissected. It also supports the view that the 
p-subunit is a potential stimulator of CK2 activity also when 
calmodulin is the substrate, although this property is normally 
masked by the predominant negative influence of other parts 
of its molecule. 
4. Discussion 
Although the regulation of CK2 activity is still a matter of 
conjecture a breakthrough in this problem recently came from 
the observation that its non-catalytic B-subunit plays a dual 
role, by conferring improved stability and higher activity to the 
catalytic subunit while imposing, at the same time, a kind of 
intrinsic down-regulation on it [6,7]. The discrimination be- 
tween these two opposite effects, whose balance ultimately de- 
termine the basal activity of CK2, was made possible by recon- 
stitution experiments with mutatedp-subunits [6,7] in conjunc- 
tion with the use of substrates that perceive to different extents 
the ‘positive’ and ‘negative’ regulatory effects. 
In particular a number of acidic residues clustered in the 
N-terminal moiety of the P-subunit (sequence 55-64 and possi- 
bly the autophosphorylation site at the very N-terminal end) 
were shown to be implicated in down-regulation [6,13], which 
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becomes especially evident when calmodulin is the substrate [7]. 
In contrast the deletion of the carboxyl-terminal part, from 
residue 170 to the end, prevented the association with the a- 
subunit, and consequently protection against thermal inactiva- 
tion and stimulation of basal activity [6]. We have now provided 
the tangible proof that indeed the carboxyl-terminal 17&215 
domain exhibits positive regulation by mimicking both the pro- 
tection against thermal inactivation and the stimulation of 
basal activity that are among the specific features of the p- 
subunit. Interestingly a truncated peptide (/I[ 170-l 921) lacking 
the last 23 amino acids is still able to stimulate basal activity 
but has lost the ability to prevent thermal inactivation. This 
would indicate that the stimulatory and protective potentials 
rely on distinct structural features, and that the latter but not 
the former requires the integrity of a segment downstream of 
residue 192. Interestingly the phosphoacceptor site for cdc2 
kinase is located within this deleted segment (Ser-209) suggest- 
ing that its phosphorylation, which has been shown neither to 
affect activity [14] nor holoenzyme assembly [15], might be 
implicated in the stability of CK2 and hence its turnover. 
By sharp contrast to the positive effects of the /I-subunit, 
which are mimicked by the 170-2 15 peptide, the down-regula- 
tory potential of the B-subunit is totally absent in this peptide, 
as proved by its inability to prevent calmodulin phosphoryla- 
tion, which instead is stimulated to the same extent as that of 
canonical substrates, or even more so. This finding also sug- 
gests that calmodulin phosphorylation might not be exempt 
from the stimulatory effect of the p-subunit but that under 
basal conditions this effect is totally masked by overwhelming 
negative regulation, at least in vitro. 
The lack of down-regulation by peptide /I[ 170-2151 is in 
agreement with the concept that this negative property is de- 
pendent on acidic residues in the N-terminal moiety of the 
P-subunit, with special reference to those in the 55564 sequence 
[6,7]. This conclusion is further strengthened by the finding that 
a peptide reproducing the 55-71 sequence is in some way com- 
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Fig. 4. Phosphorylation of calmodulin by CK2a subunit either alone 
(lane 1) or after addition of equimolar amounts of /?-subunit (lane 2) 
and increasing amounts of peptidesj3[170&215] (lanes 3-5) orp[55571] 
(lanes 5-7). The amounts of peptides /?[170-2151 and /$55571] are ex- 
pressed as their molar ratios vs. the a-subunit. Radiolabeled calmodulin 
was resolved by SDS-PAGE and detected by autoradiography [7]. The 
positions to where the P-subunit and calmodulin (CaM) migrated are 
indicated on the margin. 
114 0. Marin et al./FEBS Letters 363 (199.5) 111~114 
plementary to /?[170-2151 in that it fails to either protect or 
activate, while it significantly reduces the basal activity of the 
a-subunit, in a dose dependent manner. 
It should be noted that both /3[170-2151 and, even more so, 
p[Y-711 need to be in large molar excess over the a-subunit in 
order to display their effect, while the whole B-subunit is effec- 
tive at equimolar concentrations. This does not invalidate the 
conclusion that our data reflect the mimetic properties of the 
peptides. The possibility in fact that their efficacy might be 
merely accounted for by unspecific interactions with the cata- 
lytic site of the enzyme is ruled out by two lines of evidence: 
firstly their effect is only evident with the a-subunit, but not, 
at comparable concentrations, with the holoenzyme composed 
of two a- and two j&subunits; secondly the /?[170-2151 peptide 
counteracts in a dose-dependent and reversible manner the 
stimulatory effect of the p-subunit by preventing its association 
with the a-subunit, as expected if they are competing for the 
same binding site(s). 
It is not surprising on the other hand that the whole /3- 
subunit would display much higher affinity for the a-subunit 
than peptides reproducing, to the best, 20% of its length (see 
Fig. 1A). The synthesis of larger/l fragments and the generation 
of new truncated mutants will provide the tools for assessing 
whether high affinity binding is retained by the whole isolated 
activatory domain or strictly depends on the integrity of the 
jl molecule inclusive of its down-regulatory site(s) as well. 
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